Streptomyces clavuligerus

From Wikipedia, the free encyclopedia
Streptomyces clavuligerus
Scientific classification
Kingdom: Bacteria
Phylum: Actinobacteria
Order: Actinomycetales
Family: Streptomycetaceae
Genus: Streptomyces
Species: S. clavuligerus
Binomial name
Streptomyces clavuligerus
Higgens & Kastner 1971

Streptomyces clavuligerus is a species of Gram-positive bacterium that produces clavulanic acid.[1]

S. clavuligerus ATCC 27064 (NRRL 3585, DSM 738) was first described by Higgens and Kastner, who isolated it from a South American soil sample.[2] Its name refers to the shape of its spore-bearing hyphal branches: from the Latin, clavula, meaning little club, and igerus, meaning bearing. S. clavuligerus spores are gray to grayish-green.[2]

S. clavuligerus produces over 20 secondary metabolites, including many beta-lactam antibiotics such as clavulanic acid, cephamycin C, deacetoxycephalosporin C, penicillin N (an intermediate in cephamycin C pathway), and at least four other clavams.[3][4] Non-β-lactam antibiotics include holomycin and an antibiotic complex, MM 19290, related to tunicamycin;[5] a beta-lactamase-inhibitory protein (BLIP) has also been described.[6]

Another important characteristic of S. clavuligerus is that it is not able to use glucose as a carbon source because it lacks a glucose transport system.[7][8]

It also possesses all the enzymes of the urea cycle, which is unusual for a prokaryote, although it is not clear whether the urea cycle is functional.[9]

References

  1. Reading C, Cole M (1977). "Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from Streptomyces clavuligerus". Antimicrob Agents Chemother 11 (5): 852–7. PMC 352086. PMID 879738. 
  2. 2.0 2.1 Higgens CE, Kastner RE (1971). "Streptomyces clavuligerus sp. nov., a beta-lactam antibiotic producer". International Journal of Systematic Bacteriology 21 (4): 32631. doi:10.1099/00207713-21-4-326. 
  3. Nabais AMA, Dafonseca MMR (1995). "The Effect of Solid Medium Composition on Growth and Sporulation of Streptomyces-Clavuligerus - Spore Viability During Storage at +4-Degrees-C". Biotechnology Techniques 9 (5): 3614. doi:10.1007/BF00638871. 
  4. Tahlan K, Anders C, Jensen S (2004). "The Paralogous Pairs of Genes Involved in Clavulanic Acid and Clavam Metabolite Biosynthesis Are Differently Regulated in Streptomyces clavuligerus". J Bacteriol 186 (18): 6286–97. doi:10.1128/JB.186.18.6286-6297.2004. PMC 515150. PMID 15342599. 
  5. Baggaley K, Brown A, Schofield C (1997). "Chemistry and biosynthesis of clavulanic acid and other clavams". Nat Prod Rep 14 (4): 309–33. doi:10.1039/np9971400309. PMID 9281835. 
  6. Doran J, Leskiw B, Aippersbach S, Jensen S (1990). "Isolation and characterization of a beta-lactamase-inhibitory protein from Streptomyces clavuligerus and cloning and analysis of the corresponding gene". J Bacteriol 172 (9): 4909–18. PMC 213145. PMID 2203736. 
  7. Aharonowitz Y, Demain A (1 August 1978). "Carbon Catabolite Regulation of Cephalosporin Production in Streptomyces clavuligerus". Antimicrob Agents Chemother 14 (2): 159–64. PMC 352426. PMID 697343. 
  8. Garcia-Dominguez M, Martin J, Liras P (1989). "Characterization of sugar uptake in wild-type Streptomyces clavuligerus, which is impaired in glucose uptake, and in a glucose-utilizing mutant". J Bacteriol 171 (12): 6808–14. PMC 210580. PMID 2687256. 
  9. Kirk S (2000). The physiology of clavulanic acid production by Streptomyces clavuligerus (PhD thesis). University of Surrey, UK. 

External links

This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.